Last updated: 11/03/2018 20:57:48

TOCTINO® for severe chronic hand eczema – post observation of successful treated patients in TOCCATATOCCATA N

GSK study ID
200793
See study documents
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: TOCTINO® for severe chronic hand eczema – post observation of successful treated patients in TOCCATA
Trial description: Follow up due to time to relapse in a post treatment period on patients who achieved 'clear' or 'almost clear' hands following the initial treatment in the TOCCATA study. If they relapsed within the post observational period, a second course of TOCTINO® oral retinoid (Alitretinoin) could be started and efficacy and safety of a second course was assessed. TOCTINO® is a registered trademark of the GlaxoSmithKline group of companies.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

PGA

Timeframe: 18 months

Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
51
Primary completion date:
Not applicable
Observational study model:
Cohort
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Eczema
Product
alitretinoin
Collaborators
Not applicable
Study date(s)
July 2009 to November 2013
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
none
  • Patients with chronic hand eczema who achieved a PGA “clear” or “almost clear” in the TOCCATA study
Inclusion and exclusion criteria
Inclusion criteria:
  • Patients with chronic hand eczema who achieved a PGA “clear” or “almost clear” in the TOCCATA study

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

Scientific result summary
Available language(s): English
Download document(s)

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2013-15-11

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website